Thoughts, Words, Action: The Alma-Ata Declaration to Diabetes Care Transformation Sanjay KalraZhanay A. AkanovAlex Y. Pleshkova Editorial Open access 09 May 2018 Pages: 873 - 876
Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review Jerry Meece Review Open access 24 March 2018 Pages: 877 - 890
Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis Kirsten NørgaardNithya SukumarPonnusamy Saravanan Review Open access 05 April 2018 Pages: 891 - 917
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk Edison GoncalvesDavid S. H. Bell Review Open access 05 April 2018 Pages: 919 - 926
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus Riccardo CandidoKathleen WyneEster Romoli Review Open access 13 April 2018 Pages: 927 - 949
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States Lars WilkinsonBarnaby HuntRichard F. Pollock Original Research Open access 19 March 2018 Pages: 951 - 961
The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis Pan-wei MuDe-zhao LiuYan-ming Chen Original Research Open access 21 March 2018 Pages: 963 - 971
A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes Neil WebbMichelle OrmeJakob Langer Original Research Open access 24 March 2018 Pages: 973 - 986
Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial Qing SuJun LiuWenying Yang Original Research Open access 24 March 2018 Pages: 987 - 999
Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Hitoshi IshiiHiroki ShinYasuhiro Akai Original Research Open access 29 March 2018 Pages: 1001 - 1019
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis Ruixuan JiangErnest LawRaafat Seifeldin Original Research Open access 29 March 2018 Pages: 1021 - 1036
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System Witesh ParekhSophie E. StreetonGiulio Marchesini Original Research Open access 29 March 2018 Pages: 1037 - 1047
Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study Fumitaka OkajimaYuko NakamuraNaoya Emoto Original Research Open access 04 April 2018 Pages: 1049 - 1059
Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis Feng Huang Original Research Open access 04 April 2018 Pages: 1061 - 1072
A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs Yingping YiYawei LiHua Xu Original Research Open access 05 April 2018 Pages: 1073 - 1082
Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance Masakazu HanedaTakashi KadowakiMakoto Ueno Original Research Open access 10 April 2018 Pages: 1083 - 1097
Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes Magaly Perez-NievesKristina S. BoyeMaureen J. Lage Original Research Open access 11 April 2018 Pages: 1099 - 1111
Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Wei ChenYubin WuYubao Hu Original Research Open access 11 April 2018 Pages: 1113 - 1124
Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis Shuichi SuzukiUrvi DesaiMagaly Perez-Nieves Original Research Open access 16 April 2018 Pages: 1125 - 1141
A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study Tsuyoshi OkuraKei TeramotoKazuhiro Yamamoto Original Research Open access 17 April 2018 Pages: 1143 - 1147
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Anti-Diabetic Drugs Michal WitkowskiLars WilkinsonHrvoje Vrazic Original Research Open access 19 April 2018 Pages: 1149 - 1167
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin Lawrence BlondeDenis RaccahBruno Guerci Original Research Open access 19 April 2018 Pages: 1169 - 1184
Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey Hiroki MurayamaKota ImaiMasato Odawara Original Research Open access 25 April 2018 Pages: 1185 - 1199
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia Nebojša LalićMonika Russel-SzymczykBarrie Chubb Original Research Open access 26 April 2018 Pages: 1201 - 1216
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK Richard F. PollockWilliam J. ValentineOn behalf of the DEVOTE Study Group Original Research Open access 30 April 2018 Pages: 1217 - 1232
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin Michal WitkowskiLars WilkinsonHrvoje Vrazic Original Research Open access 30 April 2018 Pages: 1233 - 1251
Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial Ting-Ting YinYan BiDa-Long Zhu Original Research Open access 09 May 2018 Pages: 1253 - 1267
Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis Xia DaiZu-chun LuoFeng Huang Original Research Open access 09 May 2018 Pages: 1269 - 1277
Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years Qian LiRahul GangulyTam Dang-Tan Original Research Open access 09 May 2018 Pages: 1279 - 1293
The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study Yanjin HuJia LiuYuan Xu Original Research Open access 12 May 2018 Pages: 1295 - 1305
Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis Andrew E. UlokoBaba M. MusaKabiru B. Sada Original Research Open access 14 May 2018 Pages: 1307 - 1316
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies Henry N. GinsbergMichel FarnierHelen M. Colhoun Original Research Open access 19 May 2018 Pages: 1317 - 1334
Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Qiang WangHao LiuJiawang Ding Original Research Open access 19 May 2018 Pages: 1335 - 1345
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA Lawrence BlondeLuigi MeneghiniRory J. McCrimmon Brief Report Open access 29 March 2018 Pages: 1347 - 1358
Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study Analía RamosFernanda RabasaAntonio Pérez Brief Report Open access 03 May 2018 Pages: 1359 - 1367
Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus Eveline BruinstroopLaura MeyerP. Sytze van Dam Brief Report Open access 19 May 2018 Pages: 1369 - 1375
Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating a “Chicken and Egg” Paradigm in Ketosis-Prone Diabetes Runbo SongShanjin Cao Case Report Open access 29 March 2018 Pages: 1377 - 1383
Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report Ken TakeshimaHiroyuki AriyasuTakashi Akamizu Case Report Open access 03 May 2018 Pages: 1385 - 1395
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol William HintonMichael FeherSimon de Lusignan STUDY PROTOCOL Open access 31 March 2018 Pages: 1397 - 1402
Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial Tomoya MitaToru HiyoshiHirotaka Watada Study Protocol Open access 09 May 2018 Pages: 1403 - 1412
Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study Alessandro CiresiEnrica VigneriCarla Giordano Author Correction Open access 10 April 2018 Pages: 1413 - 1413